167 related articles for article (PubMed ID: 24116015)
1. Serum glycan markers for evaluation of disease activity and prediction of clinical course in patients with ulcerative colitis.
Miyahara K; Nouso K; Saito S; Hiraoka S; Harada K; Takahashi S; Morimoto Y; Kobayashi S; Ikeda F; Miyake Y; Shiraha H; Takaki A; Okada H; Amano M; Hirose K; Nishimura S; Yamamoto K
PLoS One; 2013; 8(10):e74861. PubMed ID: 24116015
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of high-throughput glycome analysis in patients with pancreatic cancer.
Nouso K; Amano M; Ito YM; Miyahara K; Morimoto Y; Kato H; Tsutsumi K; Tomoda T; Yamamoto N; Nakamura S; Kobayashi S; Kuwaki K; Hagihara H; Onishi H; Miyake Y; Ikeda F; Shiraha H; Takaki A; Nakahara T; Nishimura S; Yamamoto K
J Gastroenterol; 2013 Oct; 48(10):1171-9. PubMed ID: 23307043
[TBL] [Abstract][Full Text] [Related]
3. Alteration of serum N-glycan profile in patients with autoimmune pancreatitis.
Tomoda T; Nouso K; Kato H; Miyahara K; Dohi C; Morimoto Y; Kinugasa H; Akimoto Y; Matsumoto K; Yamamoto N; Noma Y; Horiguchi S; Tsutsumi K; Amano M; Nishimura S; Yamamoto K
Pancreatology; 2016; 16(1):44-51. PubMed ID: 26723536
[TBL] [Abstract][Full Text] [Related]
4. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X
J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of a serum glycome analysis in patients with colorectal cancer.
Takei D; Harada K; Nouso K; Miyahara K; Dohi C; Matsushita H; Kinugasa H; Hiraoka S; Nishimura SI; Okada H
J Gastroenterol Hepatol; 2022 Apr; 37(4):727-733. PubMed ID: 35064597
[TBL] [Abstract][Full Text] [Related]
6. Significance of Serum N-glycan Profiling as a Diagnostic Biomarker in Urothelial Carcinoma.
Oikawa M; Hatakeyama S; Yoneyma T; Tobisawa Y; Narita T; Yamamoto H; Hashimoto Y; Koie T; Narita S; Sasaki A; Tsuchiya N; Habuchi T; Takahashi I; Nakaji S; Ohyama C
Eur Urol Focus; 2018 Apr; 4(3):405-411. PubMed ID: 28753809
[TBL] [Abstract][Full Text] [Related]
7. A [Glyco]biomarker that Predicts Failure to Standard Therapy in Ulcerative Colitis Patients.
Pereira MS; Maia L; Azevedo LF; Campos S; Carvalho S; Dias AM; Albergaria A; Lima J; Marcos-Pinto R; Lago P; Pinho SS
J Crohns Colitis; 2019 Jan; 13(1):39-49. PubMed ID: 30239648
[TBL] [Abstract][Full Text] [Related]
8. Use of non-invasive serum glycan markers to distinguish non-alcoholic steatohepatitis from simple steatosis.
Yamasaki Y; Nouso K; Miyahara K; Wada N; Dohi C; Morimoto Y; Kinugasa H; Takeuchi Y; Yasunaka T; Kuwaki K; Onishi H; Ikeda F; Miyake Y; Nakamura S; Shiraha H; Takaki A; Iwasaki Y; Amano M; Nishimura S; Yamamoto K
J Gastroenterol Hepatol; 2015 Mar; 30(3):528-34. PubMed ID: 25168691
[TBL] [Abstract][Full Text] [Related]
9. Serum N-glycan profiles in patients with intraductal papillary mucinous neoplasms of the pancreas.
Akimoto Y; Nouso K; Kato H; Miyahara K; Dohi C; Morimoto Y; Kinugasa H; Tomoda T; Yamamoto N; Tsutsumi K; Kuwaki K; Onishi H; Ikeda F; Nakamura S; Shiraha H; Takaki A; Okada H; Amano M; Nishimura S; Yamamoto K
Pancreatology; 2015; 15(4):432-8. PubMed ID: 26052067
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of serum procalcitonin in patients with ulcerative colitis.
Koido S; Ohkusa T; Takakura K; Odahara S; Tsukinaga S; Yukawa T; Mitobe J; Kajihara M; Uchiyama K; Arakawa H; Tajiri H
World J Gastroenterol; 2013 Dec; 19(45):8335-41. PubMed ID: 24363525
[TBL] [Abstract][Full Text] [Related]
11. Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.
Lee SH; Kim MJ; Chang K; Song EM; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD
BMC Gastroenterol; 2017 Oct; 17(1):110. PubMed ID: 29061121
[TBL] [Abstract][Full Text] [Related]
12. Plasma N-Glycan Signatures Are Associated With Features of Inflammatory Bowel Diseases.
Clerc F; Novokmet M; Dotz V; Reiding KR; de Haan N; Kammeijer GSM; Dalebout H; Bladergroen MR; Vukovic F; Rapp E; ; Targan SR; Barron G; Manetti N; Latiano A; McGovern DPB; Annese V; Lauc G; Wuhrer M
Gastroenterology; 2018 Sep; 155(3):829-843. PubMed ID: 29792883
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of serum N-glycan profiling as a diagnostic and prognostic biomarker in germ-cell tumors.
Narita T; Hatakeyama S; Yoneyama T; Narita S; Yamashita S; Mitsuzuka K; Sakurai T; Kawamura S; Tochigi T; Takahashi I; Nakaji S; Tobisawa Y; Yamamoto H; Koie T; Tsuchiya N; Habuchi T; Arai Y; Ohyama C
Cancer Med; 2017 Apr; 6(4):739-748. PubMed ID: 28317343
[TBL] [Abstract][Full Text] [Related]
14. Alpha-1 antitrypsin and granulocyte colony-stimulating factor as serum biomarkers of disease severity in ulcerative colitis.
Soendergaard C; Nielsen OH; Seidelin JB; Kvist PH; Bjerrum JT
Inflamm Bowel Dis; 2015 May; 21(5):1077-88. PubMed ID: 25803506
[TBL] [Abstract][Full Text] [Related]
15. Soluble ST2: a new and promising activity marker in ulcerative colitis.
Díaz-Jiménez D; Núñez LE; Beltrán CJ; Candia E; Suazo C; Alvarez-Lobos M; González MJ; Hermoso MA; Quera R
World J Gastroenterol; 2011 May; 17(17):2181-90. PubMed ID: 21633527
[TBL] [Abstract][Full Text] [Related]
16. Monocytosis and a Low Lymphocyte to Monocyte Ratio Are Effective Biomarkers of Ulcerative Colitis Disease Activity.
Cherfane CE; Gessel L; Cirillo D; Zimmerman MB; Polyak S
Inflamm Bowel Dis; 2015 Aug; 21(8):1769-75. PubMed ID: 25993688
[TBL] [Abstract][Full Text] [Related]
17. Elevated colonic microbiota-associated paucimannosidic and truncated N-glycans in pediatric ulcerative colitis.
Li H; Zhang X; Chen R; Cheng K; Ning Z; Li J; Twine S; Stintzi A; Mack D; Figeys D
J Proteomics; 2021 Oct; 249():104369. PubMed ID: 34481999
[TBL] [Abstract][Full Text] [Related]
18. Correlations between the serum bilirubin level and ulcerative colitis: a case-control study.
Shi H; Feng Y; Jiang J; Zhao J; Li X; Liu X
Eur J Gastroenterol Hepatol; 2019 Aug; 31(8):992-997. PubMed ID: 31205128
[TBL] [Abstract][Full Text] [Related]
19. Serum IL-17A in newly diagnosed treatment-naive patients with ulcerative colitis reflects clinical disease severity and predicts the course of disease.
Ohman L; Dahlén R; Isaksson S; Sjöling A; Wick MJ; Sjövall H; Van Oudenhove L; Simrén M; Strid H
Inflamm Bowel Dis; 2013 Oct; 19(11):2433-9. PubMed ID: 23966065
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome.
Trbojević Akmačić I; Ventham NT; Theodoratou E; Vučković F; Kennedy NA; Krištić J; Nimmo ER; Kalla R; Drummond H; Štambuk J; Dunlop MG; Novokmet M; Aulchenko Y; Gornik O; Campbell H; Pučić Baković M; Satsangi J; Lauc G;
Inflamm Bowel Dis; 2015 Jun; 21(6):1237-47. PubMed ID: 25895110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
